Safety and Efficacy Study of Intentional Delivery in Women With Preterm and Prelabour Rupture of the Membranes
This study has been terminated.
(The DSMB supported termination of the trial due to slow recruitment.)
Sponsor:
University of Alberta
Collaborator:
Stollery Children's Hospital Foundation
Information provided by:
University of Alberta
ClinicalTrials.gov Identifier:
NCT00259519
First received: November 25, 2005
Last updated: April 5, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Two-year multicentre randomized controlled parallel trial to compare intentional delivery and conservative management in pregnant women with preterm and prelabour rupture of membranes between 32 and 35 weeks.
The purpose of this study is to determine whether intentional delivery of women with PPROM between 32 and 35 week's gestation can decrease the overall neonatal morbidity associated with PPROM-related complications without increasing the morbidity associated with a shortened pregnancy.
| Condition | Intervention |
|---|---|
|
Fetal Membranes, Premature Rupture |
Procedure: Induction of delivery |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effects of Intentional Delivery After Preterm and Prelabor Rupture of Membranes Between 32 and 35 Weeks of Gestation: A Multicentre Randomized and Controlled Trial |
Resource links provided by NLM:
Further study details as provided by University of Alberta:
Primary Outcome Measures:
- Length of Stay in hospital [ Time Frame: time between birth and readiness for discharge ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- MAIN Score (Morbidity Assessment Index for Newborns) [ Time Frame: From birth to discharge ] [ Designated as safety issue: No ]
- Early Onset Neonatal Sepsis [ Time Frame: from birth to discharge ] [ Designated as safety issue: No ]
- Clinical and Histological Chorioamnionitis [ Time Frame: from birth to discharge ] [ Designated as safety issue: No ]
- Antepartum Length of stay [ Time Frame: From diagnosis to delivery ] [ Designated as safety issue: No ]
- C-Section [ Time Frame: delivery ] [ Designated as safety issue: Yes ]
| Enrollment: | 152 |
| Study Start Date: | January 2006 |
| Estimated Study Completion Date: | September 2011 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: 1
Expectant management
|
|
|
Active Comparator: 2
Induction of delivery
|
Procedure: Induction of delivery
Induction of delivery
Other Name: immediate delivery
|
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Women with recent PPROM between 31 weeks + 6 days and 35 weeks + 6 days (estimated gestational age based on an ultrasound examination before 18 weeks of gestation), not in labour 24 hours after admission*, will be considered eligible for the study provided the following inclusion criteria (*For patients transferred from a remote level 2 centre to one of the participating sites within the first hours after PPROM, the onset of the 24-hour screening period will be the time of admission in the centre of origin. Patients in Group A will be given their first dose of antenatal steroids before the transfer)
- Single and otherwise uncomplicated pregnancy
- Recent history (less than 48 hours) of leaking with the two followings within 24 hours after primary medical assessment: Documentation of fluid from the vagina and Positive Fern test, or positive Nitrazine test, or Positive ACTIM PROM test
- Antenatal steroids course initiated after the rupture for women with PPROM between 31 + 6 and 33 + 6 weeks
- Normal fetal heart rate trace using an external ultrasound transducer
- Written informed consent obtained before inclusion and randomization
Exclusion Criteria:
- Multiple pregnancy
- HIV positive mother
- Active HSV cervical lesions
- Major fetal anomaly on ultrasound examination performed after admission
- Intrauterine growth restriction estimated on ultrasound below the 5th percentile or preeclampsia
- Placenta abruption present at the time of the diagnosis of PPROM or occurring within the first 24 hours after rupture
- Clinical chorioamnionitis existing before or at the time of the diagnosis of PPROM or developing within the first 24 hours after rupture
- Non-reassuring fetal testing present at the time of the diagnosis of PPROM or occurring within the first 24 hours after the rupture. It implies that expected criteria for standard fetal assessment parameters have not been met, including the Non-Stress test and the Biophysical profile Score. This will be diagnosed at the discretion of the attending physician.
- More generally, any maternal or fetal reason for an immediate delivery, either existing at admission or occurring within the 24 hours after admission.
- Mother refusal or inability to provide consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00259519
Locations
| Canada, Alberta | |
| Foothills Hospital | |
| Calgary, Alberta, Canada | |
| Royal Alexandra Hospital | |
| Edmonton, Alberta, Canada, T5H3V9 | |
| Grey Nuns Community Hospital | |
| Edmonton, Alberta, Canada, T6L 5X8 | |
| Caritas - Misericordia Hospital | |
| Edmonton, Alberta, Canada, T6R 4H5 | |
| Canada, British Columbia | |
| BC Women's Hospital and Health Centre | |
| Vancouver, British Columbia, Canada, V6H 3N1 | |
| Canada, Manitoba | |
| Women's Hospital | |
| Winnipeg, Manitoba, Canada, R3L 0W8 | |
| St. Boniface General Hospital | |
| Winnipeg, Manitoba, Canada, R2H 2A6 | |
| Canada, Ontario | |
| Saint-Joseph Health Care | |
| London, Ontario, Canada, N6A 4V2 | |
| Canada, Quebec | |
| Sainte-Justine Hospital | |
| Montreal, Quebec, Canada | |
| Laval University Hospital | |
| Quebec City, Quebec, Canada | |
| Canada, Saskatchewan | |
| Royal University Hospital | |
| Saskatoon, Saskatchewan, Canada, S7N 0W8 | |
Sponsors and Collaborators
University of Alberta
Stollery Children's Hospital Foundation
Investigators
| Principal Investigator: | Thierry Lacaze-Masmonteil, MD, PhD | University of Alberta |
| Principal Investigator: | Radha Chari, MD,FRCPC | University of Alberta- Department of Gynecology and Obstetrics |
More Information
No publications provided
| Responsible Party: | Dr Thierry Lacaze-Masmonteil, University of Alberta - Department of Pediatrics |
| ClinicalTrials.gov Identifier: | NCT00259519 History of Changes |
| Other Study ID Numbers: | N041000314 |
| Study First Received: | November 25, 2005 |
| Last Updated: | April 5, 2010 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by University of Alberta:
|
premature or preterm birth chorioamnionitis neonatal sepsis labour |
Cesarean Section delivery length of stay pregnancy |
Additional relevant MeSH terms:
|
Fetal Membranes, Premature Rupture Rupture Obstetric Labor Complications Pregnancy Complications Wounds and Injuries |
ClinicalTrials.gov processed this record on June 18, 2013